⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
ANVS
SUPN
ABBV
VNDA
JAZZ
ACAD
MRK
The Ophthalmology Foundation Welcomes Eight Distinguished Leaders to Its Board of Directors
accessnewswire.com
JNJ
ABBV
ENT Disorder Treatment Market to Reach US$58 Billion by 2034, Driven by Digital Diagnostics and Minimally Invasive Car
globenewswire.com
GSK
SNY
PFE
AZN
NVS
ABBV
JNJ
MRK
MDT
SN
BSX
TEVA
SUN
Duchenne Muscular Dystrophy Treatment Market Report (2025-2034) Published, Segments Intravenous, Subcutaneous, and Oral Routes Across Three Pharmacy Channels
globenewswire.com
SRPT
PFE
BIIB
REGN
GILD
JNJ
ABBV
NVS
SNY
CAPR
SLDB
WVE
EDIT
Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board
prnewswire.com
ABBV
Presbyopia Market Forecast to Reach Approximately USD 18 Billion by 2036 as Pharmacological Innovation Accelerates
globenewswire.com
ABBV
Complicated Urinary Tract Infections Market Report, Analyzes Treatment Needs Across Elderly, Diabetic, and Immunosuppressed Populations
globenewswire.com
ABBV
PFE
GALT
VKTX
LPCN
ALGS
LLY
Juvenile Idiopathic Arthritis Market is Forecast to Grow at a 4.6% CAGR from 2026 to 2036 As Biologics, JAK Inhibitors, and Emerging Targeted Therapies Reshape Pediatric Arthritis Treatment.
globenewswire.com
ABBV
SNY
REGN
JNJ
NVS
BMY
LLY
PFE
UCB
SkinMedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development
prnewswire.com
ABBV
Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape
globenewswire.com
AMGN
AZN
JNJ
NVS
ABBV
AKBA
ARDX
CHNR
LLY
FGEN
GILD
GSK
NVO
PFE